Financial Year |
March 31 2023 |
Monetary Funds |
24,662,506,612.84 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
-- |
Accounts Receivable |
763,575,412.21 |
Advances to Suppliers |
449,853,761.65 |
Other Receivables |
52,489,749,153.92 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
448,276,724.90 |
Inventories |
150,441,725,266.57 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
5,838,553,751.00 |
Total Current Assets |
234,678,753,666.44 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
177,976,000.00 |
Long-term Equity Investment |
30,557,456,132.79 |
Investment Properties |
8,387,898,485.31 |
Fixed Assetes |
1,613,735,213.38 |
Under-construction Projects |
43,688,231.02 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
16,193,578.72 |
R&D expenses |
-- |
Goodwill |
18,620,669.81 |
Long-Term Deferred and Prepaid Expenses |
338,619,964.13 |
Deferred Income Tax Assets |
3,036,756,556.27 |
Other Non-Current Assets |
520,805,639.67 |
Sub-Total of Non-Current Assets |
48,732,685,649.76 |
Total Assets |
283,411,439,316.20 |
Short-Term Loans |
20,000,000.00 |
Trading Financial liabilities |
-- |
Notes Payable |
50,800,097.34 |
Accounts Payable |
9,223,927,357.43 |
Accounts Received In Advance |
55,998,798.91 |
Employee Compensation Payable |
30,939,272.21 |
Taxes Payable |
1,341,542,636.84 |
Interest Payable |
-- |
Dividend Payable |
167,024,937.29 |
Other payables |
19,463,596,760.12 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
13,910,924,877.04 |
Other Current Liabilities |
9,302,403,562.66 |
Sub-Total of Current Liabilities |
104,738,629,537.35 |
Long-term Loans |
48,664,251,239.20 |
Bonds Payable |
62,131,264,071.97 |
Long-Term Accounts Payable |
3,642,009,617.37 |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
447,371,871.86 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
115,471,985,363.34 |
Total Liabilities |
220,210,614,900.69 |
Paid-In Capital(Or Share Stock) |
2,579,565,242.00 |
Capital Surplus |
7,645,920,122.02 |
Surplus Reserve |
1,934,746,046.42 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
11,591,356,179.73 |
Minority Stockholder's Interest |
38,109,051,283.63 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
25,091,773,131.88 |
Owner's Equity(Stockholder's Equity) |
63,200,824,415.51 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
283,411,439,316.20 |